CorMedix Inc. — Director's Dealing 2015

Mar 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2015-03-02

Reporting Person: TELLEZ CORA M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-02	Stock Option (right to buy)	$5.62	A	50000	Acquired	2025-03-01	Common Stock, $0.001 par value per share (50000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.001 par value per share	63386	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.05	2024-04-03	Common Stock, $0.001 par value per share (30000)	30000	Direct
Common Stock Warrants (right to buy)	$0.9	2020-01-08	Common Stock, $0.001 par value per share (25000)	25000	Direct

Footnotes

F1: These shares vest 1/3 on date of grant, 1/3 on first anniversary of date of grant and 1/3 on second anniversary of date of grant.

F2: On January 8, 2014, the reporting person acquired through a private placement, (i) 5,000 shares of the Company's Series C-3 Non-Voting Convertible Preferred Stock, each share convertible into 10 shares of Common Stock, $0.001 par value per share (and which were converted to common stock on October 29, 2014); and (ii) a five-year warrant to purchase common Stock at an exercise price of $1.25 per share. The Series C-3 Non-voting Convertible Preferred Stock and warrants were purchased together at a purchase price of $10.00 per share. The warrant exercise price was decreased to $0.90 per share effective September 15, 2014.

F3: The options vest in full on the first anniversary of the date of grant.